Markets:

Overview

News

Currencies

International

Treasuries

Nkarta, Inc. - Common Stock (NQ:NKTX)

2.515 +0.105 (+4.36%)

Streaming Delayed Price Updated: 2:35 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nkarta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗

October 08, 2024

Via Benzinga

Why Nkarta Stock Is Soaring Today ↗

August 14, 2024

One analyst is now more bullish about this clinical-stage biotech stock.

Via The Motley Fool

UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday ↗

August 14, 2024

Via Benzinga

Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

August 14, 2024

Via Benzinga

NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024 ↗

August 13, 2024

NKTX stock results show that Nkarta beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

NKTX Stock Earnings: Nkarta Beats EPS for Q1 2024 ↗

May 09, 2024

NKTX stock results show that Nkarta beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights

August 13, 2024

From Nkarta, Inc.

Via GlobeNewswire

Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights

August 13, 2024

From Nkarta, Inc.

Via GlobeNewswire

Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President

July 16, 2024

From Nkarta, Inc.

Via GlobeNewswire

3 Undervalued Stocks Primed for a 2X Return ↗

July 01, 2024

Discover compelling investment opportunities with top undervalued stocks for high returns leading in healthcare and software.

Via InvestorPlace

Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications

June 27, 2024

From Nkarta, Inc.

Via GlobeNewswire

Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights

May 09, 2024

From Nkarta, Inc.

Via GlobeNewswire

Opportunity Alert: 3 Undiscovered Stocks About to Explode on Wall Street’s Radar ↗

May 07, 2024

Explore these undiscovered stock picks attached with rapid growth in biotechnology, oil and gas, and pharmaceuticals.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 12, 2024

Via Benzinga

Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing ↗

April 11, 2024

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D...

Via Benzinga

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors

April 08, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors

April 05, 2024

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors

April 05, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

Nasdaq Turns Higher; Akanda Shares Plunge ↗

March 25, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also...

Via Benzinga

Topics Stocks

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 25, 2024

Via Benzinga

Crude Oil Moves Higher; US New Home Sales Fall In February ↗

March 25, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 25, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 25, 2024

We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning.

Via InvestorPlace

Nkarta Announces Pricing of $240 Million Underwritten Offering

March 25, 2024

From Nkarta, Inc.

Via GlobeNewswire

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 22, 2024

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Via Benzinga

Stocks Level Off, S&P 500 Nears Best Week Of 2024, NVIDIA Rallies For 11th Week, Bitcoin Sinks: What's Driving Markets Friday? ↗

March 22, 2024

Stocks slightly retreated during New York’s morning session on Friday, following another robust week of gains fueled by a dovish Federal Reserve meeting, which underscored Chair Jerome Powell‘s...

Via Benzinga

Topics Economy Stocks

Why Is Cancer Drug-Developer Nkarta Stock Trading Lower On Friday? ↗

March 22, 2024

Nkarta closed patient enrollment in NKX101 clinical trial, reallocating focus to lead program NKX019 for autoimmune disease. Recent expansion into autoimmune disease with FDA clearance for NKX019 in...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 22, 2024

Via Benzinga

Why Top 1% Biotech Stock Nkarta Just Plummeted, Undercutting Its 50-Day Line ↗

March 22, 2024

The company is deprioritizing a key piece of its pipeline in favor of a potential lupus treatment.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Nkarta, Inc. - Common Stock (NQ:NKTX)

All News about Nkarta, Inc. - Common Stock

Starting at /week.